These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18794033)

  • 1. Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services.
    Wellman GS; Vidican C
    Res Social Adm Pharm; 2008 Sep; 4(3):218-30. PubMed ID: 18794033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Judgment processes in older adults' drug benefit evaluations.
    Cline RR; Gupta K
    Res Social Adm Pharm; 2005 Mar; 1(1):5-20. PubMed ID: 17138463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
    Kirking DM; Ascione FJ; Richards JW
    Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting demand among older adults for medication therapy management services.
    Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007.
    Schommer JC; Planas LG; Johnson KA; Doucette WR
    J Am Pharm Assoc (2003); 2008; 48(4):478-86. PubMed ID: 18647710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employee knowledge of a managed pharmacy benefit in a large corporation.
    Miller MJ; Desselle SP
    Manag Care Interface; 2005 Jan; 18(1):33-42. PubMed ID: 15682630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug benefit decisions among older adults: a policy-capturing analysis.
    Cline RR; Gupta K
    Med Decis Making; 2006; 26(3):273-81. PubMed ID: 16751326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of information on preferences stated in a choice-based conjoint analysis.
    van Til JA; Stiggelbout AM; Ijzerman MJ
    Patient Educ Couns; 2009 Feb; 74(2):264-71. PubMed ID: 18954956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder.
    Harpe SE; Szeinbach SL; Caswell RJ; Corey R; McAuley JW
    J Urol; 2007 Dec; 178(6):2532-6; discussion 2536. PubMed ID: 17937937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of a pharmacy resident in an assisted living facility-based medication therapy management program.
    Maack B; Miller DR; Johnson T; Dewey M
    Ann Pharmacother; 2008 Nov; 42(11):1613-20. PubMed ID: 18940921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experiment on simplifying conjoint analysis designs for measuring preferences.
    Maddala T; Phillips KA; Reed Johnson F
    Health Econ; 2003 Dec; 12(12):1035-47. PubMed ID: 14673812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-provided telephonic medication therapy management in an MAPD plan.
    Ward MA; Xu Y
    Am J Manag Care; 2011 Oct; 17(10):e399-409. PubMed ID: 21999720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does choice in model selection affect maximum likelihood analysis?
    Ripplinger J; Sullivan J
    Syst Biol; 2008 Feb; 57(1):76-85. PubMed ID: 18275003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    Hofheinz R; Clouth J; Borchardt-Wagner J; Wagner U; Weidling E; Jen MH; Brück P
    BMC Cancer; 2016 Dec; 16(1):937. PubMed ID: 27923357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using choice-based conjoint to determine the relative importance of dental benefit plan attributes.
    Cunningham MA; Gaeth GJ; Juang C; Chakraborty G
    J Dent Educ; 1999 May; 63(5):391-9. PubMed ID: 10410159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Rural Health; 2009; 25(3):290-5. PubMed ID: 19566615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How consumers choose health insurance.
    Chakraborty G; Ettenson R; Gaeth G
    J Health Care Mark; 1994; 14(1):21-33. PubMed ID: 10134041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.